Quiero saber acerca de...

40862

Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices
Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS
Dated: July 23, 2021.
David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202116160 Filed 72821; 8:45 am
https www.nichd.nih.gov/about/
meetings/2021/092321.
Alison N. Cernich, Deputy Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.
FR Doc. 202116118 Filed 72821; 8:45 am BILLING CODE 414001P

BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institutes of Health
National Institutes of Health Workshop on Exploring the Science Surrounding the Safe Use of Bioactive Ingredients in Infant Formula:
Considerations for an Assessment Framework National Institutes of Health, Health and Human Services HHS.
ACTION: Notice.
AGENCY:

This 2-day, virtual workshopExploring the Science Surrounding the Safe Use of Bioactive Ingredients in Infant Formula:
Considerations for an Assessment Frameworkfocuses on the functional state-of-the-science of biologically active human milk components and analogs and the implications for safety assessments when used in infant formula.

SUMMARY:

The Meeting will be held on September 2324, 2021, from 10:30 a.m.
to 4:30 p.m. ET.
ADDRESSES: This workshop will be videocast at https videocast.nih.gov.
FOR FURTHER INFORMATION CONTACT: For information concerning this meeting, contract Dr. Ashley Vargas, Pediatric Growth and Nutrition Branch, Division of Extramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, 6701B
Rockledge Drive, Room 2423C, Bethesda, MD 20817, telephone: 301
8276030, email: ashley.vargas@
nih.gov.
DATES:

This Federal Register notice is in accordance with 42 U.S.C. 285g, of the Public Health Service Act, as amended. This workshop is led by the Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD, the National Institutes of Health NIH Office of Dietary Supplements ODS, and the Food and Drug Administration FDA. The workshop is free and open to the public.
The workshop will be livestreamed, and the video will be archived. Registration will be available for this meeting at
jbell on DSKJLSW7X2PROD with NOTICES

SUPPLEMENTARY INFORMATION:

VerDate Sep<11>2014

19:19 Jul 28, 2021

Jkt 253001

National Cancer Institute; Notice of Closed Meetings Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis Panel; IMAT
Biospecimen Research.
Date: September 30, 2021.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W246, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Jun Fang, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W246, Rockville, Maryland 20850, 2402765460, jfang@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; SEP2: NCI
Clinical and Translational Cancer Research.
Date: October 2021, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W264, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Ombretta Salvucci, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W264, Rockville, Maryland 20850, 2402767286, salvucco@
mail.nih.gov.

PO 00000

Frm 00061

Fmt 4703

Sfmt 4703

Name of Committee: National Cancer Institute Initial Review Group; Transition to Independence Study Section I.
Date: October 2021, 2021.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W602, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Delia Tang, M.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W602, Rockville, Maryland 20850, 2402766456, tangd@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; SEP3: NCI
Clinical and Translational Cancer Research.
Date: October 2122, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W102, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Shuli Xia, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W102, Rockville, Maryland 20850, shuli.xia@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; SEP8: NCI
Clinical and Translational Cancer Research.
Date: November 45, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W126, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Susan Lynn Spence, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W126, Rockville, Maryland 20850, susan.spence@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; SEP4: NCI
Clinical and Translational Cancer Research.
Date: November 45, 2021.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W254, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Eduardo Emilio Chufan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W254, Rockville, Maryland 20850, 2402767975, chufanee@
mail.nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction;

E:FRFM29JYN1.SGM

29JYN1